西西河

主题:聊聊新冠,乱七八糟的瞎扯 -- 普鲁托

共:💬222 🌺786 🌵16
全看分页树展 · 主题 跟帖
家园 搞错了,看漏了一行。你是对的。

搞错了,看漏了一行。你是对的。

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.

今天,美国食品药品监督管理局(Food and Drug Administration)对辉瑞公司的 Paxlovid(尼玛瑞韦片剂和利托那韦片剂,共同包装用于口服)颁发了紧急使用授权(EUA),用于治疗轻度至中度成人和儿童(12 岁及以上,体重至少 40 公斤(88磅))COVID-19患者(经由直接 SARS-CoV-2 病毒检测结果为阳性),并且有高风险发展为严重 COVID-19(包括住院或死亡)的患者。

FDA NEWS RELEASE - Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19

全看分页树展 · 主题 跟帖


有趣有益,互惠互利;开阔视野,博采众长。
虚拟的网络,真实的人。天南地北客,相逢皆朋友

Copyright © cchere 西西河